About the job
Established in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a dynamic, well-financed biotechnology company listed on Nasdaq, providing a thrilling opportunity to be part of an innovative team. At Apogee, you will have the chance to influence our organizational culture, take on diverse responsibilities, and advance your career in a collaborative environment.
As a clinical-stage biotechnology firm, we are committed to developing groundbreaking biologics that demonstrate superior efficacy and dosing in major inflammatory and immunology markets. Our antibody programs aim to address the shortcomings of current therapies by targeting established mechanisms of action and utilizing advanced antibody engineering to enhance their properties. Our lead program, Zumilokibart (APG777), is being developed primarily for atopic dermatitis (AD) and asthma. With four validated targets, Apogee is on a mission to deliver best-in-class efficacy through both monotherapies and combinations of innovative antibodies. Our strong pipeline and experienced leadership position us to provide significant value and improvements for patients who are currently underserved by existing treatments.
We pride ourselves on our fast-paced and exceptional culture, grounded in our C.O.R.E. values: Caring, Original, Resilient, and Egoless, as we strive for excellence beyond the status quo.
If this resonates with you, we invite you to explore further!
We are looking for a dedicated and experienced patent attorney to join our intellectual property team in a pivotal new role. As the Director of Patent Attorney, you will be instrumental in preparing and prosecuting patent applications specifically within the life sciences sector, with a keen focus on antibodies. You will conduct patent landscape analyses, offer patentability assessments, and identify and mitigate freedom-to-operate risks. The ideal candidate will demonstrate initiative, teamwork, and possess exceptional interpersonal and communication skills.
Key Responsibilities
- Prepare and prosecute patent applications related to life sciences, particularly antibody technologies.

